Medtronic proposes a promising solution to the increasing challenges of health systems with the help of technologies. It is expected to speed up the efficiency of health systems substantially. Medtronic is an American-Irish medical device provider primarily operating in the United States with Headquarters in Dublin, Ireland.
The establishment is extensively utilizing artificial intelligence (AI) coupled with robotic-assisted surgery, data analytics, and predictive modelling. is establishing a robust foundation displaying a modern era of personalized medicine. It emphasizes on how technology will offer efficient, accessible, and equitable healthcare. Medtronic is set on a mission to alleviate patient’s pain, restore health and enhance life quality. To achieve the same, the company has developed a team of over 90,000 brightest minds, committed to simplify major challenges of the healthcare system. Engineers at Medtronic are utilising AI, and machine learning to screen the massive amount of data.
They are working towards developing next-gen sensing technologies expanding the capabilities of neurotransmitters, pacemakers, insulin pumps, and surgical robots. Medtronic smart devices display quality designing and development of the devices. They are typically smaller in size, designed to work faster, and ultimately help patients deal with the enervating diseases such as diabetes, and cancer.
Medtronic has already set its benchmark with the broad portfolio of leadless pacemakers, the very first leadless pacemakers to win FDA approval. The company advanced significantly in miniaturisation, and battery technology. As a result, Medtronic was able to develop the world’s smallest pacemaker about the size of a multivitamin.